The neuroprotection of liraglutide on alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice

Journal of Alzheimer's Disease

Volumn 37, Issue 3, 2013, Pages 623-635

  Xiong, Hui ^a   Zheng, Chen ^a   Wang, Jingjing ^a   Song, Jinzhi ^a   Zhao, Gang ^a   Shen, Hui ^a   Deng, Yanqiu ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; liraglutide; neurofilaments; streptozotocin; tau

Indexed keywords

CYTOSKELETON PROTEIN; INSULIN; LIRAGLUTIDE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROFILAMENT PROTEIN; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLYCOSYLATION; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; MALE; MEMORY DISORDER; MICROTUBULE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GLUCAGON-LIKE PEPTIDE 1; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENTRICULAR; INSULIN; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; NEUROFILAMENT PROTEINS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84892690389     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130584     Document Type: Article

References (31)

1. Iqbal K, Grundke-Iqbal (2008) Alzheimer neurofibrillary degeneration: Significance, etiopathogenesis, therapeutics and prevention. J Cell Mol Med 12, 28-55.
2. Jones A, Kulozik P, Ostertag A, Herzig S (2009) Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes. J Alzheimers Dis 16, 787-808.
3. De la Monte SM, Tong M, Lester-Coll N, Plater M J, Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: Relevance to Alzheimer's disease. J Alzheimers Dis 10, 89-109.
4. Parthsarathy V, Hölscher C (2013) Chronic yreatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons inan AD mouse model. PLoS One 8, e58784.
5. Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Plácido A, Santos MS, Oliveira CR, Moreira PI (2013) Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurode-generation. Biochim Biophys Acta 1832, 27-41.
6. Ye X, Carp RI, Schmued LC, Scallet AC (2001) Fluoro-Jade and silver methods: Application to the neuropathology of scrapie, a transmissible spongiform encephalopathy. Brain Res Brain Res Protoc 8, 104-112.
7. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11, 47-60.
8. Veeranna, Kaji T, Boland B, Odrljin T, Mohan P, Basavara-jappa BS, Peterhoff C, Cataldo A, Rudnicki A, Amin N, Li BS, Pant HC, Hungund BL, Arancio O, Nixon RA (2004) Calpain mediates calcium-induced activation of the ERK1, 2 MAPK pathway and cytoskeletal phosphorylation in neurons relevance to Alzheimer's disease. Am J Pathol 165, 795-805.
9. Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, Lippa CF, Ono S, Okazawa H (2000) JNK activation is associated with intracellular beta-amyloid accumulation. Brain Res Mol Brain Res 85, 221-233.
10. Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong CX (2009) Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease. Am J Pathol 175, 2089-2098.
11. Shingo AS, Kanabayashi T, Kito S, Murase T (2013) Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in rats. Behav Brain Res 241, 105-111.
12. Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX (2013) A non-transgenic mouse model (icv-STZ Mouse) of Alzheimer's disease: Similarities to and differences from the transgenic model (3xTg-AD mouse). Mol Neurobiol 47, 711-725.
13. Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease? Ageing Res Rev 10, 264-273.
14. Sato N, Takeda S, Uchio-Yamada K, Ueda H, Fujisawa T, Rakugi H, Morishita R (2011) Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: A missing link to therapeutic potential. Curr Aging Sci 4, 118-127.
15. Gao M, Tian H, Ma C, Gao X, Guo W, Yao W (2010) Expression, purification, and C-terminal site-specific PEGylation of cysteine-mutated glucagon-like peptide-1. Appl Biochem Biotechnol 162, 155-165.
16. McClean PL, Parthsarathy V, Faivre E, Hölscher C (2011) The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 31, 6587-6594.
17. Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH (2003) Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J Neurosci Res 72, 603-612.
18. Druga R, Mares P, Otáhal J, Kubová H (2005) Degenerative neuronal changes in the rat thalamus induced by status epilepticus at different developmental stages. Epilepsy Res 63, 43-65.
19. Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, Masliah E (2008) Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulin. J Neurosci Res 86, 3265-3274.
20. Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS (2006) Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes 55, 3320-3325.
21. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7, 656-664.
22. Wang D, Fu Q, Zhou Y, Xu B, Shi Q, Igwe B, Matt L, Hell JW, Wisely EV, Oddo S, Xiang YK (2013) |32 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer's disease models. J Biol Chem 288, 10298-10307.
23. Ploia C, Antoniou X, Sclip A, Grande V, Cardinetti D, Colombo A, Canu N, Benussi L, Ghidoni R, Forloni G, Borsello T (2011) JNK plays a key role in tau hyperphos-phorylation in Alzheimer's disease models. J Alzheimers Dis 26, 315-329.
24. Yu Y, Run X, Liang Z, Li Y, Liu F, Liu Y, Iqbal K, Grundke-Iqbal I, Gong CX (2009) Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases. J Neu-rochem 108, 1480-1494.
25. Zhao H, Wang SL, Qian L, Jin JL, Li H, Xu Y, Zhu XL (2013) Diammonium glycyrrhizinate attenuates Afj (1-42)-induced neuroinflammation and regulates MAPK and NF-/cB pathways in vitro and in vivo. CNS Neurosci Ther 19, 117-124.
26. Schechter R, Beju D, Miller KE (2005) The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem Biophys Res Commun 334, 979-986.
27. Shiraki A, Oyama J, Komoda H, Asaka M, Komatsu A, Sakuma M, Kodama K, Sakamoto Y, Kotooka N, Hirase T, Node K (2012) The glucagon-like peptide 1 analog liraglutide reduces TNF-a-induced oxidative stress and inflammation in endothelial cells. Atherosclerosis 221, 375-382.
28. Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribe E, Dalfo E, Avila J (2005) Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Curr Alzheimer Res 2, 3-18.
29. Liu F, Shi J, Tanimukai H, Gu J, Gu J, Grundke-Iqbal I, Iqbal K, Gong CX (2009) Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 132, 1820-1832.
30. Deng Y, Li B, Liu F, Iqbal K, Grundke-Iqbal I, Brandt R, Gong CX (2008) Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease. FASEB J 22, 138-145.
31. Gong CX, Liu F, Iqbal K (2012) O-GlcNAc cycling modulates neurodegeneration. Proc Natl Acad Sci USA 109, 17319-17320.